UBS Group
CVM icon

UBS Group’s CEL-SCI Corp CVM Stock Holding History

UBS Group’s Portfolio CVM Stock Details CVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.4K Buy
16,637
+3,444
+26% +$16K ﹤0.01% 7332
2025
Q4 		$69.4K Sell
13,193
-2,331
-15% -$17.1K ﹤0.01% 7076
2025
Q3 		$143K Sell
15,524
-14,293
-48% -$112K ﹤0.01% 6881
2025
Q2 		$68.3K Buy
29,817
+26,741
+869% +$140K ﹤0.01% 7533
2025
Q1 		$21.2K Sell
3,076
-160
-5% -$1.73K ﹤0.01% 8195
2024
Q4 		$38.8K Buy
3,236
+1,724
+114% +$39.8K ﹤0.01% 7463
2024
Q3 		$48.1K Sell
1,512
-2,535
-63% -$89.4K ﹤0.01% 6840
2024
Q2 		$141K Buy
4,047
+2,303
+132% +$98.1K ﹤0.01% 5920
2024
Q1 		$99.9K Buy
1,744
+1,000
+134% +$70.7K ﹤0.01% 6226
2023
Q4 		$60.7K Buy
744
+216
+41% +$13.5K ﹤0.01% 6442
2023
Q3 		$19.8K Buy
528
+25
+5% +$1.2K ﹤0.01% 6813
2023
Q2 		$36.3K Buy
503
+36
+8% +$2.62K ﹤0.01% 6637
2023
Q1 		$32.5K Sell
467
-252
-35% -$19.7K ﹤0.01% 6737
2022
Q4 		$50.7K Buy
719
+474
+193% +$41.7K ﹤0.01% 6760
2022
Q3 		$22K Buy
245
+78
+47% +$9.4K ﹤0.01% 7249
2022
Q2 		$23K Sell
167
-39
-19% -$4.06K ﹤0.01% 6694
2022
Q1 		$24K Sell
206
-7,039
-97% -$1.15M ﹤0.01% 7237
2021
Q4 		$1.54M Sell
7,245
-480
-6% -$147K ﹤0.01% 3977
2021
Q3 		$2.55M Buy
7,725
+6,874
+808% +$2M ﹤0.01% 3376
2021
Q2 		$221K Sell
851
-1,998
-70% -$1.24M ﹤0.01% 5268
2021
Q1 		$1.3M Buy
2,849
+2,550
+853% +$1.39M ﹤0.01% 3988
2020
Q4 		$105K Buy
299
+105
+54% +$41.4K ﹤0.01% 5653
2020
Q3 		$74K Sell
194
-1,444
-88% -$569K ﹤0.01% 5366
2020
Q2 		$733K Buy
1,638
+954
+139% +$392K ﹤0.01% 3802
2020
Q1 		$237K Sell
684
-493
-42% -$180K ﹤0.01% 4590
2019
Q4 		$323K Buy
1,177
+804
+216% +$190K ﹤0.01% 5223
2019
Q3 		$100K Buy
373
+249
+201% +$58.4K ﹤0.01% 5767
2019
Q2 		$32K Sell
124
-55
-31% -$9.95K ﹤0.01% 6281
2019
Q1 		$19K Buy
179
+137
+326% +$11.8K ﹤0.01% 6341
2018
Q4 		$4K Hold
42
– – ﹤0.01% 7619
2018
Q3 		$5K Buy
42
+32
+320% +$1.84K ﹤0.01% 7477
2018
Q2 		$0 Hold
10
– – ﹤0.01% 8019
2018
Q1 		$0 Hold
10
– – ﹤0.01% 7861
2017
Q4 		$1K Hold
10
– – ﹤0.01% 7700
2017
Q3 		$0 Hold
10
– – ﹤0.01% 7754
2017
Q2 		$1K Sell
10
-176
-95% -$12.3K ﹤0.01% 7483
2017
Q1 		$12K Buy
186
+173
+1,331% +$13.8K ﹤0.01% 6501
2016
Q4 		$0 Sell
13
-53
-80% -$8.14K ﹤0.01% 7798
2016
Q3 		$15K Buy
66
+52
+371% +$17.6K ﹤0.01% 6513
2016
Q2 		$5K Sell
14
-20
-59% -$7.87K ﹤0.01% 7113
2016
Q1 		$13K Buy
34
+9
+36% +$3.44K ﹤0.01% 6490
2015
Q4 		$7K Sell
25
-10
-29% -$3.9K ﹤0.01% 7499
2015
Q3 		$16K Buy
35
+10
+40% +$4.58K ﹤0.01% 6897
2015
Q2 		$12K Buy
25
+17
+213% +$10.8K ﹤0.01% 7304
2015
Q1 		$6K Sell
8
-4
-33% -$2.62K ﹤0.01% 7999
2014
Q4 		$5K Buy
+12
New +$5.92K ﹤0.01% 8957

Other funds holding CVM

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

UBS Group's CVM Position: Q1 2026 in Review

UBS Group increased its CEL-SCI Corp (CVM) stake by 26% in Q1 2026, buying an estimated $16K and bringing the position to 16,637 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #7332.

UBS Group first reported a position in CVM in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.55M in Q3 2021. 39 funds tracked by Wall St. Rank hold CVM as of Q1 2026.

  • UBS Group held 16,637 shares of CEL-SCI Corp worth $53.4K as of Q1 2026.
  • UBS Group bought 3,444 CEL-SCI Corp shares in Q1 2026, an estimated $16K.
  • CEL-SCI Corp made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7332 holding.
  • UBS Group first reported a position in CEL-SCI Corp in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's CEL-SCI Corp position peaked at $2.55M in Q3 2021.
  • 39 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.